FONT-SIZE Plus   Neg

Monsanto Posts Higher Q2 Profit; Ups FY12 EPS View - Quick Facts

Monsanto Co. (MON) posted an improvement in its second-quarter net income attributable to the company to $1.21 billion from year-ago quarter's $1.02 billion, with quarterly earnings per share growing to $2.24 from $1.88 last year, helped by the strong performance of the seeds and traits business and the timing of an early U.S. season.

Earnings per share from ongoing business for the recent quarter were $2.28, higher than $1.87 in the comparable period. On average, 20 analysts polled by Thomson Reuters expected earnings per share of $2.12 for the quarter. Analysts' estimates typically exclude one-time items.

Net sales totaled $4.75 billion compared with $4.13 billion in the previous year, while 13 analysts estimated revenues of $4.53 billion for the quarter.

For fiscal 2012, the company currently sees earnings per share of $3.45 - $3.50 on a reported basis and $3.49 - $3.54 on an ongoing basis. Previously, the company estimated to achieve $3.39 - $3.44 of ongoing and as-reported earnings per share for fiscal 2012. Twenty-two analysts project earnings of $3.51 per share for the full year.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Apple confirmed that it has bought face animation software firm Faceshift, although it was tight lipped about how it intends to use the new addition. The move is speculated as a bid to expand into virtual reality. Environment ministry of South Korea Thursday ordered Volkswagen Korea to recall 125,522 diesel vehicles on determining actual emissions of nitrogen oxides. The ministry has asked the German automobile maker to pay a fine of 14.1 billion Won or $12.31 million. The company has to submit a recall plan by January 6, 2016. The U.S. Food and Drug Administration has alerted health care professionals and patients of a voluntary recall of compounded multivitamin capsules containing high amounts of Vitamin D3 (Cholecalciferol), distributed nationwide by Glades Drugs in Pahokee, Florida. FDA has received reports of several...
comments powered by Disqus
Trade MON now with 
Follow RTT